SG11202000785VA - Systems and methods for performing a real-time glycan assay of a sample - Google Patents

Systems and methods for performing a real-time glycan assay of a sample

Info

Publication number
SG11202000785VA
SG11202000785VA SG11202000785VA SG11202000785VA SG11202000785VA SG 11202000785V A SG11202000785V A SG 11202000785VA SG 11202000785V A SG11202000785V A SG 11202000785VA SG 11202000785V A SG11202000785V A SG 11202000785VA SG 11202000785V A SG11202000785V A SG 11202000785VA
Authority
SG
Singapore
Prior art keywords
real
sample
systems
methods
glycan assay
Prior art date
Application number
SG11202000785VA
Inventor
Chao-Hsiang Wu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG11202000785VA publication Critical patent/SG11202000785VA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8804Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 automated systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202000785VA 2017-08-01 2018-08-01 Systems and methods for performing a real-time glycan assay of a sample SG11202000785VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762539798P 2017-08-01 2017-08-01
PCT/US2018/044891 WO2019028191A1 (en) 2017-08-01 2018-08-01 Systems and methods for performing a real-time glycan assay of a sample

Publications (1)

Publication Number Publication Date
SG11202000785VA true SG11202000785VA (en) 2020-02-27

Family

ID=63350601

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000785VA SG11202000785VA (en) 2017-08-01 2018-08-01 Systems and methods for performing a real-time glycan assay of a sample

Country Status (16)

Country Link
US (1) US12025618B2 (en)
EP (1) EP3662288B1 (en)
JP (1) JP7184819B2 (en)
KR (1) KR102577670B1 (en)
CN (1) CN110892267B (en)
AU (1) AU2018312564A1 (en)
BR (1) BR112020001922A2 (en)
CA (1) CA3071636A1 (en)
CL (1) CL2020000250A1 (en)
EA (1) EA202090380A1 (en)
ES (1) ES2978397T3 (en)
IL (1) IL271500B1 (en)
MA (1) MA49758A (en)
MX (1) MX2020001171A (en)
SG (1) SG11202000785VA (en)
WO (1) WO2019028191A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019009817A (en) 2017-02-17 2019-11-21 Denali Therapeutics Inc Anti-tau antibodies and methods of use thereof.
EP4397977A3 (en) * 2019-02-14 2024-09-11 Amgen Inc. Systems and methods for preparing a sample and performing a real-time assay of the sample
GB202003336D0 (en) * 2020-03-06 2020-04-22 National Institute For Bioprocesisng Res And Training A system for producing a biopharmaceutical product

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264327A (en) * 1978-04-21 1981-04-28 Blum Alvin S Method and apparatus for automatic competitive binding analysis
JPH0269655A (en) * 1988-09-05 1990-03-08 Japanese Res & Dev Assoc Bio Reactor Syst Food Ind On-line automatic analyzing instrument for bioreactor
JPH05227943A (en) * 1991-07-26 1993-09-07 Nippon Millipore Kogyo Kk Automatic apparatus for culturing
EP0610297A1 (en) * 1991-09-30 1994-08-17 Perseptive Biosystems, Inc. Protein chromatography system
CA2146177C (en) 1995-04-03 2000-09-05 Adrian P. Wade Intelligent flow analysis network
US6887429B1 (en) * 2001-01-26 2005-05-03 Global Fia Apparatus and method for automated medical diagnostic tests
ATE531390T1 (en) 2001-08-23 2011-11-15 Genmab As INTERLEUKIN-15 (IL-15) SPECIFIC HUMAN ANTIBODIES
US20030095897A1 (en) * 2001-08-31 2003-05-22 Grate Jay W. Flow-controlled magnetic particle manipulation
US20040009567A1 (en) 2001-12-28 2004-01-15 Mds Proteomics Inc. Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry
US20040053356A1 (en) * 2001-12-28 2004-03-18 Mds Proteomics Inc. Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry
BR0309703A (en) * 2002-04-30 2005-02-09 Biowhittaker Technologies Inc Automated Sequential Injection Analysis Systems for Determination of Endotoxin Trace Levels
US20040009597A1 (en) 2002-07-03 2004-01-15 Isis Pharmaceuticals Inc. Antisense modulation of PTPRK expression
CA2589860A1 (en) 2005-01-24 2006-08-03 Amgen Inc. Humanized anti-amyloid antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8298763B2 (en) * 2007-03-02 2012-10-30 Lawrence Livermore National Security, Llc Automated high-throughput flow-through real-time diagnostic system
JP2010530233A (en) 2007-06-20 2010-09-09 アイアールエム・リミテッド・ライアビリティ・カンパニー Methods and compositions for treating allergic diseases
US20110117601A1 (en) * 2007-08-31 2011-05-19 Markus Haberger Glycosylation Profile Analysis
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
TWI516501B (en) 2008-09-12 2016-01-11 禮納特神經系統科學公司 Pcsk9 antagonists
US20130171658A1 (en) * 2010-09-17 2013-07-04 Prozyme, Inc. Isolation and deglycosylation of glycoproteins
US20140030732A1 (en) 2012-07-25 2014-01-30 Agilent Technologies, Inc. Microfluidic hplc-chip for glycopeptide analysis with integrated hilic enrichment
US9322014B1 (en) 2012-11-28 2016-04-26 Sandia Corporation Multiplexed microfluidic approach for nucleic acid enrichment
KR102560646B1 (en) 2017-08-01 2023-07-27 암젠 인크 Systems and methods for real-time preparation of polypeptide samples for analysis by mass spectrometry
EP4397977A3 (en) 2019-02-14 2024-09-11 Amgen Inc. Systems and methods for preparing a sample and performing a real-time assay of the sample

Also Published As

Publication number Publication date
WO2019028191A1 (en) 2019-02-07
MX2020001171A (en) 2020-03-12
KR20200035987A (en) 2020-04-06
CA3071636A1 (en) 2019-02-07
ES2978397T3 (en) 2024-09-11
US20200240993A1 (en) 2020-07-30
EP3662288B1 (en) 2024-02-28
EA202090380A1 (en) 2020-05-21
JP2020530101A (en) 2020-10-15
JP7184819B2 (en) 2022-12-06
AU2018312564A1 (en) 2020-01-30
EP3662288A1 (en) 2020-06-10
MA49758A (en) 2020-06-10
WO2019028191A9 (en) 2020-01-09
CL2020000250A1 (en) 2020-08-21
CN110892267A (en) 2020-03-17
US12025618B2 (en) 2024-07-02
KR102577670B1 (en) 2023-09-12
BR112020001922A2 (en) 2020-08-04
IL271500A (en) 2020-02-27
CN110892267B (en) 2024-08-09
IL271500B1 (en) 2024-06-01

Similar Documents

Publication Publication Date Title
ZA201901986B (en) Devices and methods for sample analysis
ZA201901985B (en) Devices and methods for sample analysis
IL250282A0 (en) High-throughput sample processing systems and methods of use
EP3377890A4 (en) Systems and methods for pooling samples from multi-well devices
EP3458953A4 (en) Systems and methods for model-based analysis of software
EP3430410A4 (en) Systems and methods for automated analysis
EP3429752A4 (en) Systems and methods for performing biological assays
EP3455730A4 (en) Systems and methods for model-based analysis of software
GB201715362D0 (en) Systems and methods for automated evaluation of human speech
EP3391058A4 (en) Systems and methods for automated analysis
GB201719634D0 (en) Systems and methods for determining point of interest
SG11201706367WA (en) Systems and methods for assessing biological samples
SG10202001197UA (en) Systems and methods for biological analysis
EP3325935A4 (en) Method and system for pipeline condition analysis
PL3411151T3 (en) A microfluidic assay system and a method of performing an assay
EP3155640A4 (en) Sample analysis systems and methods of use thereof
AU2018100401A4 (en) Systems and methods for automating the application of friction-modifying coatings
EP3721377A4 (en) Systems and methods of efficiently performing biological assays
EP3512862A4 (en) Devices and methods for sample analysis
EP3204537A4 (en) Glycan analysis and profiling
EP3110565A4 (en) Systems and methods for automating the application of friction-modifying coatings
EP3570980A4 (en) Methods and devices for sample analysis
IL271500A (en) Systems and methods for performing a real-time glycan assay of a sample
EP3682024A4 (en) Methods and systems for automated sample processing
EP3631414A4 (en) Assay systems and methods for processing sample entities